13F Data
13F filer · CIK 1839948

TCG Crossover Management, LLC

PALO ALTO, CA · filing since Q4 2021 · last filing Aug 14, 2026
Reported value
$4.2B
+$665.1M vs prior
Positions
54
New / sold out
12 / 7
Added / reduced
2 / 9
Turnover
12.4%
buys $475.1M · sells $492.4M
Top-10 weight
57.4%

Biggest buys vs Q1 2026

ChangeSecurityShares changeChange %Est. trade value
NewZAI LAB LTD-ADR+6,137,627–+$116.6M
NewAURA BIOSCIENCES INC+9,533,333–+$67.7M
NewFIRST TRACKS BIOTHERAPEUTICS+2,895,304–+$58.3M
AddedAVALO THERAPEUTICS INC+2,278,737+308.6%+$42.1M
NewEDITAS MEDICINE INC+11,111,111–+$36.0M
NewPHARVARIS BV+1,008,229–+$34.9M
NewINFLARX N V+14,500,000–+$32.5M
NewALTIMMUNE INC+10,000,000–+$30.4M
NewAKTIS ONCOLOGY INC+696,560–+$22.5M
NewFORTE BIOSCIENCES INC+920,000–+$19.6M
4 more rows. Subscribe for $29/month to see every row, download the data and use the API.

Biggest sells vs Q1 2026

ChangeSecurityShares changeChange %Est. trade value
Sold outCENTESSA PHARMACEUTICALS PLC-4,286,480-100.0%$-170.3M
ReducedABIVAX SA AMERICAN DEPOSITARY SHARES-473,251-7.3%$-63.1M
ReducedTANGO THERAPEUTICS INC-1,449,870-13.8%$-45.3M
ReducedREVOLUTION MEDICINES INC-235,574-40.9%$-44.1M
ReducedBIOHAVEN LTD-2,851,365-61.6%$-42.4M
Sold outFULCRUM THERAPEUTICS INC-5,250,000-100.0%$-40.3M
ReducedALX ONCOLOGY HOLDINGS INC-7,356,362-56.5%$-15.2M
Sold outLIQUIDIA TECHNOLOGIES INC-403,048-100.0%$-15.2M
ReducedARVINAS HOLDING CO LLC-1,680,363-70.4%$-14.0M
ReducedLB PHARMACEUTICALS INC-392,179-21.3%$-12.7M
6 more rows. Subscribe for $29/month to see every row, download the data and use the API.

Estimated trade value = change in shares × this quarter's implied price. 13F filings show quarter-end positions, not individual trades.

Reported value by quarter

Q4 2021: $213.6MQ1 2022: $249.1MQ2 2022: $235.4MQ3 2022: $333.4MQ4 2022: $566.6MQ1 2023: $513.0MQ2 2023: $609.8MQ3 2023: $679.1MQ4 2023: $901.7MQ1 2024: $1.3BQ2 2024: $959.5MQ3 2024: $1.2BQ4 2024: $1.0BQ1 2025: $733.1MQ2 2025: $875.5MQ3 2025: $2.0BQ4 2025: $3.0BQ1 2026: $3.5BQ2 2026: $4.2B
Q4 2021Q2 2026

Holdings · Q2 2026

#SecuritySharesValueWeight
1ABIVAX SA AMERICAN DEPOSITARY SHARESCOMM6,007,834$800.6M19.24%
2TANGO THERAPEUTICS INCCOMM9,081,201$283.9M6.82%
3CG ONCOLOGY INCCOMM3,670,206$260.8M6.27%
4COGENT BIOSCIENCES INCCOMM4,854,436$187.9M4.52%
5IMMUNOVANT INCCOMM4,457,988$171.8M4.13%
6SPYRE THERAPEUTICS INCCOMM1,900,582$168.7M4.06%
7DIANTHUS THERAPEUTICS INCCOMM1,676,624$163.4M3.93%
8MIRUM PHARMACEUTICALS INCCOMM1,062,049$124.3M2.99%
9ZAI LAB LTD-ADRADRS6,137,627$116.6M2.80%
10AMYLYX PHARMACEUTICALS INCCOMM6,243,812$112.1M2.70%
44 more rows. Subscribe for $29/month to see every row, download the data and use the API.